[PDF] Top 20 Aplicaciones y Funciones Trascendentales a la Ingeniería

... inhibitors, nivolumab and pembrolizumab, have been associated with a high incidence of thyroid dysfunction (11, 12, ...of nivolumab therapy for malignant melanoma and non-squamous non-small cell lung cancer ... See full document

... Our patient presented with severe DKA within 3 months of initiation of durvalumab with fulminant onset as reflected by clinical symptoms, low C-peptide and HbA1c of 7.8% with weakly positive autoantibodies. This ... See full document

... (e.g. thyroiditis, ...Non-obese diabetic (NOD) mice have been studied ex- tensively as an experimental model since they feature many aspects of T1DM similar to ... See full document

... It was first described in obese type2 patients. Even though, the insulin level is high in type 2 diabetic patients, there is low glucose utilization and insulin inaction in the adipose tissue, muscle and hepatic ... See full document

... Heparan sulfate makes up about 50-90% of the chains found in the glycocalyx and its major role is to detect flow-induced shear responses, modulate the NO response, activation of coagulation inhibition factors ... See full document

... Serum BChE activity was significantly lower in the DKA group than the other two groups (p < 0.05). Serum BChE activity is inhibited by oxidative stress and systemic inflammatory process generated in DKA; and this ... See full document

... Abstract: Thrombotic complications figure among the most frequent causes of mortality in diabetic ketoacidosis (DKA) and hyperosmolar state. We report the case of a 55-year-old woman presenting with DKA ... See full document

... In one patient case 3, who developed clinical brain edema 23 hr after initiation of insulin treatment, a third CT scan obtained 3 hr after the onset of signs and symptoms and treatment w[r] ... See full document

... Main- tenance fluids preferably contain 3 volume of isotonic solution of sodium salts and % free water ( as 5 to 10% glucose solution). Data I[r] ... See full document

... All participants (patients and controls) underwent assess- ment by Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). MMSE is a 30-point questionnaire that is applied extensively in clin- ical ... See full document

... current regimen of subcutaneous insulin therapy to that with continuous low-dose insulin infusion.. in the treatment of diabetic ketoacidosis in the.[r] ... See full document

... 5 Nivolumab injection (Bristol-Myers Squibb Holdings Pharma, ...and nivolumab injection has been approved by the FDA as fi rst- and second-line treatment for advanced ... See full document

... Background: Diabetic ketoacidosis (DKA) is a common presentation of type I diabetes mellitus to the emergency departments. Most children with DKA are initially managed in community emergency departments ... See full document

... The literature search strategy for this review relied on previously published guidelines for systematic reviews [20,21]. A number of databases including EBSCO host, encompassing Academic search premier, Medline, ... See full document

... during diabetic ketoacidosis, starvation, and growth hormone administration, there is (a) no alteration in hepatic mitochondrial function; (b) no change in the intrinsic capacity of hepatic mitochondria to ... See full document

... Accordingly, diabetic patients with overt hyperthyroidism may experience poor glycaemic control and indeed hyperthyroidism has been known to impulsive diabetic ketoacidosis in patients w[r] ... See full document

... Outpatient care utilization differs between diabetic patients with DKA hospitalizations and those without, particularly during the weeks and months preceding DKA events. ED visits, and, to a lesser degree, ... See full document

... Abstract: Immune checkpoint inhibitors have revolutionized cancer treatment due to their undeniable ef fi cacy, but a range of new adverse events (AE) has emerged. In particular, cardiac toxicity is a potentially fatal ... See full document

... After transfer to our hospital, aggres- sive fluid resuscitation was continued, and intravenous treatment with regu- lar insulin was initiated (0.1 U/kg bo- lus, followed by a continuous infusion of 0.1 U/kg per ... See full document

... Diabetic ketoacidosis (DKA)is a life-threatening acute metabolic complication of diabetes mellitus caused by complete lack of insulin in type 1diabetes mellitus or inadequate insulin levels associated with ... See full document